| MeSH term | MeSH ID | Detail |
|---|---|---|
| Gram-Negative Bacterial Infections | D016905 | 16 associated lipids |
| Uterine Cervical Diseases | D002577 | 2 associated lipids |
| Peptic Ulcer | D010437 | 19 associated lipids |
| Dermatitis | D003872 | 30 associated lipids |
| Spinal Cord Injuries | D013119 | 34 associated lipids |
| Pregnancy Complications, Infectious | D011251 | 11 associated lipids |
| Hypertension, Renal | D006977 | 9 associated lipids |
| Foot Diseases | D005534 | 4 associated lipids |
| Enteritis | D004751 | 8 associated lipids |
| Pasteurella Infections | D010326 | 8 associated lipids |
oxytetracycline
oxytetracycline is a lipid of Polyketides (PK) class. Oxytetracycline is associated with abnormalities such as Infection, X-linked centronuclear myopathy, Bacterial Infections, Heart failure and Onchocerciasis. The involved functions are known as Anabolism, physiological aspects, Transcription, Genetic, Fermentation and Transcriptional Activation. Oxytetracycline often locates in Chromosomes, Flank (surface region), Entire bony skeleton, Bone Marrow and Body tissue. The associated genes with oxytetracycline are Polypeptides, Homologous Gene, Gene Clusters, Locus and CYCS gene. The related lipids are LH 1 and Lipid Peroxides. The related experimental models are Disease model.
Cross Reference
Introduction
To understand associated biological information of oxytetracycline, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with oxytetracycline?
oxytetracycline is suspected in Infection, Helminthiasis, Nodule, Bacterial Infections, Yeast infection, pathologic fistula and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with oxytetracycline
PubChem Associated disorders and diseases
What pathways are associated with oxytetracycline
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with oxytetracycline?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with oxytetracycline?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with oxytetracycline?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with oxytetracycline?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with oxytetracycline?
Disease model
Disease model are used in the study 'A molecular ecological approach to the detection and designation of the etiological agents of a model polymicrobial disease.' (Antiabong JF et al., 2013).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with oxytetracycline
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Magonigle RA and Newby TJ | Response of cattle upon reexposure to Anaplasma marginale after elimination of chronic carrier infections. | 1984 | Am. J. Vet. Res. | pmid:6731981 |
| Roby TO et al. | Elimination of the carrier state of bovine anaplasmosis with a long-acting oxytetracycline. | 1978 | Am. J. Vet. Res. | pmid:677530 |
| Teare JA et al. | Pharmacokinetics of a long-acting oxytetracycline preparation in ring-necked pheasants, great horned owls, and Amazon parrots. | 1985 | Am. J. Vet. Res. | pmid:4083606 |
| Magonigle RA et al. | Efficacy of a new oxytetracycline formulation against clinical anaplasmosis. | 1978 | Am. J. Vet. Res. | pmid:697150 |
| George LW et al. | Effectiveness of two benzathine cloxacillin formulations for treatment of naturally occurring infectious bovine keratoconjunctivitis. | 1989 | Am. J. Vet. Res. | pmid:2774340 |
| Kniffen TS et al. | Bioavailability, pharmacokinetics, and plasma concentration of tetracycline hydrochloride fed to swine. | 1989 | Am. J. Vet. Res. | pmid:2712418 |
| Varma KJ and Paul BS | Pharmacokinetics and plasma protein binding (in vitro) of oxytetracycline in buffalo (Bubalus bubalis). | 1983 | Am. J. Vet. Res. | pmid:6838044 |
| Wooley RE et al. | Attempted reversal of oxytetracycline resistance of Proteus mirabilis by EDTA-tromethamine lavage in experimentally induced canine and feline cystitis. | 1975 | Am. J. Vet. Res. | pmid:811139 |
| Miller RA and Reimschuessel R | Epidemiologic cutoff values for antimicrobial agents against Aeromonas salmonicida isolates determined by frequency distributions of minimal inhibitory concentration and diameter of zone of inhibition data. | 2006 | Am. J. Vet. Res. | pmid:17078743 |
| Toofanian F and Targowski S | Experimental production of rabbit mucoid enteritis. | 1983 | Am. J. Vet. Res. | pmid:6346966 |
| Wooley RE et al. | In vitro action of combinations of antimicrobial agents and EDTA-tromethamine on Pseudomonas aeruginosa. | 1983 | Am. J. Vet. Res. | pmid:6414345 |
| Hewson J et al. | Impact of isoflupredone acetate treatment on clinical signs and weight gain in weanling heifers with experimentally induced Mannheimia haemolytica bronchopneumonia. | 2011 | Am. J. Vet. Res. | pmid:22126689 |
| Arnoczky SP et al. | In vitro effects of oxytetracycline on matrix metalloproteinase-1 mRNA expression and on collagen gel contraction by cultured myofibroblasts obtained from the accessory ligament of foals. | 2004 | Am. J. Vet. Res. | pmid:15077693 |
| Palmer JE et al. | Effect of treatment with oxytetracycline during the acute stages of experimentally induced equine ehrlichial colitis in ponies. | 1992 | Am. J. Vet. Res. | pmid:1476312 |
| Oukessou M et al. | Pharmacokinetics and local tolerance of a long-acting oxytetracycline formulation in camels. | 1992 | Am. J. Vet. Res. | pmid:1416372 |
| Riner JL et al. | Influence of density and location on degradation of sustained-release boluses given to cattle. | 1982 | Am. J. Vet. Res. | pmid:7181203 |
| Hidalgo RJ | Propagation of Anaplasma marginale in bovine lymph node cell culture. | 1975 | Am. J. Vet. Res. | pmid:1094867 |
| Tornquist SJ et al. | Use of a polymerase chain reaction assay to study response to oxytetracycline treatment in experimental Candidatus Mycoplasma haemolamae infection in alpacas. | 2009 | Am. J. Vet. Res. | pmid:19719425 |
| Smith JA and George LW | Treatment of acute ocular Moraxella bovis infections in calves with a parenterally administered long-acting oxytetracycline formulation. | 1985 | Am. J. Vet. Res. | pmid:4014830 |
| Myers MJ et al. | In vitro modulation of bovine blood neutrophils and mononuclear cells by oxytetracycline. | 1995 | Am. J. Vet. Res. | pmid:8533970 |